Gilmore Neil O'Neill Sarepta Therapeutics, Inc. (SRPT) insider trading activity
Gilmore Neil O'Neill is EVP, R&D & CMO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 29,070 shares of SRPT, which is worth approximately $3.75 Million. The most recent transaction as insider was on Mar 03, 2021, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
29.1K
0%
3M change
0%
12M change
Total Value Held
$3.75 Million
Gilmore Neil O'Neill Transaction History
Also insider at
GNO
Gilmore Neil O'Neill
EVP, R&D & CMO
Cambridge, MA